Chronic kidney disease (CKD) is the most common cause of death in older cats, causing progressive, often painful deterioration. Early detection and evidence-based management can significantly extend quality of life for affected cats.
CKD in cats causes progressive welfare suffering through the accumulation of uremic toxins, electrolyte imbalances, nausea, and anaemia. Because cats mask illness effectively, owners frequently do not detect CKD until it is advanced — a welfare failure that earlier diagnostic testing can prevent. Annual SDMA screening from age 7 can detect CKD at International Renal Interest Society (IRIS) Stage 1 or 2, when interventions are most effective. The welfare-oriented approach to CKD management prioritises quality of life over quantity: aggressive restriction of a cat's favourite foods in pursuit of marginal disease slowing may reduce wellbeing rather than enhance it. The goal is to maintain adequate nutrition, control nausea and hypertension, and ensure the cat remains interested in life. Subcutaneous fluid administration — taught to owners for home use — is a highly effective welfare intervention that maintains hydration and reduces uremic symptoms in advanced stages.